Ligand validation:2VXN

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VXN_GOL_A_1254	99%	78%	0.059	0.996	0.71	0.19	-	-	0	0	100%	1
2VXN_GOL_A_1253	97%	84%	0.079	0.992	0.43	0.34	-	-	0	0	100%	0.25
2VXN_GOL_A_1256	86%	38%	0.091	0.959	1.48	0.96	1	-	0	0	100%	0.73
2VXN_GOL_A_1255	84%	50%	0.102	0.964	1.06	0.88	-	-	0	0	100%	1
2VXN_GOL_A_1257	65%	46%	0.127	0.928	1.18	0.92	-	-	0	0	100%	1
1N55_GOL_A_800	77%	80%	0.123	0.963	0.27	0.56	-	-	0	0	100%	0.5
2YOQ_GOL_B_1196	100%	72%	0.019	0.996	0.68	0.42	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.